167 related articles for article (PubMed ID: 20629096)
1. Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients.
Wu CF; Pang ST; Shee JJ; Chang PL; Chuang CK; Chen CS; Liao SK; Weng WH
Genes Chromosomes Cancer; 2010 Oct; 49(10):928-34. PubMed ID: 20629096
[TBL] [Abstract][Full Text] [Related]
2. Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison.
Moussa S; Yafi FA; El-Hakim A; Fahmy N; Aprikian A; Tanguay S; Anidjar M; Kassouf W
Urol Int; 2010; 84(1):50-5. PubMed ID: 20173369
[TBL] [Abstract][Full Text] [Related]
3. Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up.
Kang CH; Chen CH; Chiang PH
Jpn J Clin Oncol; 2010 Mar; 40(3):241-6. PubMed ID: 19933687
[TBL] [Abstract][Full Text] [Related]
4. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease.
Chen CY; Liao YM; Tsai WM; Kuo HC
J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904
[TBL] [Abstract][Full Text] [Related]
5. Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?
Vauhkonen H; Böhling T; Eissa S; Shoman S; Knuutila S
Cancer Genet Cytogenet; 2007 Sep; 177(2):153-7. PubMed ID: 17854674
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
[TBL] [Abstract][Full Text] [Related]
7. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality.
Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R
Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360
[TBL] [Abstract][Full Text] [Related]
8. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
9. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
[TBL] [Abstract][Full Text] [Related]
10. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.
Luo B; Li W; Deng CH; Zheng FF; Sun XZ; Wang DH; Dai YP
Cancer Genet Cytogenet; 2009 Mar; 189(2):93-7. PubMed ID: 19215789
[TBL] [Abstract][Full Text] [Related]
11. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
[TBL] [Abstract][Full Text] [Related]
14. Collecting duct carcinomas represent a unique tumor entity based on genetic alterations.
Becker F; Junker K; Parr M; Hartmann A; Füssel S; Toma M; Grobholz R; Pflugmann T; Wullich B; Strauss A; Behnes CL; Otto W; Stöckle M; Jung V
PLoS One; 2013; 8(10):e78137. PubMed ID: 24167600
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal aberrations in urothelial carcinoma of the bladder and the World Health Organization 2004 grading system.
Brunner A; Schönhuber G; Waldner M; Schaefer G; Mikuz G; Verdorfer I
Anal Quant Cytol Histol; 2008 Oct; 30(5):297-305. PubMed ID: 18980162
[TBL] [Abstract][Full Text] [Related]
16. Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas.
Yamamoto Y; Misumi T; Eguchi S; Chochi Y; Kitahara S; Nakao M; Nagao K; Hara T; Sakano S; Furuya T; Oga A; Kawauchi S; Sasaki K; Matsuyama H
Hum Pathol; 2011 Dec; 42(12):1923-30. PubMed ID: 21683985
[TBL] [Abstract][Full Text] [Related]
17. Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis.
Armengol G; Eissa S; Lozano JJ; Shoman S; Sumoy L; Caballín MR; Knuutila S
Cancer Genet Cytogenet; 2007 Aug; 177(1):16-9. PubMed ID: 17693186
[TBL] [Abstract][Full Text] [Related]
18. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
Panani AD; Ferti AD; Raptis SA; Roussos C
Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal imbalances in small cell carcinomas of the urinary bladder.
Terracciano L; Richter J; Tornillo L; Beffa L; Diener PA; Maurer R; Gasser TC; Moch H; Mihatsch MJ; Sauter G
J Pathol; 1999 Oct; 189(2):230-5. PubMed ID: 10547580
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
